Cargando…

Friend or Foe: S100 Proteins in Cancer

S100 proteins are widely expressed small molecular EF-hand calcium-binding proteins of vertebrates, which are involved in numerous cellular processes, such as Ca(2+) homeostasis, proliferation, apoptosis, differentiation, and inflammation. Although the complex network of S100 signalling is by far no...

Descripción completa

Detalles Bibliográficos
Autores principales: Allgöwer, Chantal, Kretz, Anna-Laura, von Karstedt, Silvia, Wittau, Mathias, Henne-Bruns, Doris, Lemke, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465620/
https://www.ncbi.nlm.nih.gov/pubmed/32722137
http://dx.doi.org/10.3390/cancers12082037
_version_ 1783577628496625664
author Allgöwer, Chantal
Kretz, Anna-Laura
von Karstedt, Silvia
Wittau, Mathias
Henne-Bruns, Doris
Lemke, Johannes
author_facet Allgöwer, Chantal
Kretz, Anna-Laura
von Karstedt, Silvia
Wittau, Mathias
Henne-Bruns, Doris
Lemke, Johannes
author_sort Allgöwer, Chantal
collection PubMed
description S100 proteins are widely expressed small molecular EF-hand calcium-binding proteins of vertebrates, which are involved in numerous cellular processes, such as Ca(2+) homeostasis, proliferation, apoptosis, differentiation, and inflammation. Although the complex network of S100 signalling is by far not fully deciphered, several S100 family members could be linked to a variety of diseases, such as inflammatory disorders, neurological diseases, and also cancer. The research of the past decades revealed that S100 proteins play a crucial role in the development and progression of many cancer types, such as breast cancer, lung cancer, and melanoma. Hence, S100 family members have also been shown to be promising diagnostic markers and possible novel targets for therapy. However, the current knowledge of S100 proteins is limited and more attention to this unique group of proteins is needed. Therefore, this review article summarises S100 proteins and their relation in different cancer types, while also providing an overview of novel therapeutic strategies for targeting S100 proteins for cancer treatment.
format Online
Article
Text
id pubmed-7465620
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74656202020-09-04 Friend or Foe: S100 Proteins in Cancer Allgöwer, Chantal Kretz, Anna-Laura von Karstedt, Silvia Wittau, Mathias Henne-Bruns, Doris Lemke, Johannes Cancers (Basel) Review S100 proteins are widely expressed small molecular EF-hand calcium-binding proteins of vertebrates, which are involved in numerous cellular processes, such as Ca(2+) homeostasis, proliferation, apoptosis, differentiation, and inflammation. Although the complex network of S100 signalling is by far not fully deciphered, several S100 family members could be linked to a variety of diseases, such as inflammatory disorders, neurological diseases, and also cancer. The research of the past decades revealed that S100 proteins play a crucial role in the development and progression of many cancer types, such as breast cancer, lung cancer, and melanoma. Hence, S100 family members have also been shown to be promising diagnostic markers and possible novel targets for therapy. However, the current knowledge of S100 proteins is limited and more attention to this unique group of proteins is needed. Therefore, this review article summarises S100 proteins and their relation in different cancer types, while also providing an overview of novel therapeutic strategies for targeting S100 proteins for cancer treatment. MDPI 2020-07-24 /pmc/articles/PMC7465620/ /pubmed/32722137 http://dx.doi.org/10.3390/cancers12082037 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Allgöwer, Chantal
Kretz, Anna-Laura
von Karstedt, Silvia
Wittau, Mathias
Henne-Bruns, Doris
Lemke, Johannes
Friend or Foe: S100 Proteins in Cancer
title Friend or Foe: S100 Proteins in Cancer
title_full Friend or Foe: S100 Proteins in Cancer
title_fullStr Friend or Foe: S100 Proteins in Cancer
title_full_unstemmed Friend or Foe: S100 Proteins in Cancer
title_short Friend or Foe: S100 Proteins in Cancer
title_sort friend or foe: s100 proteins in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465620/
https://www.ncbi.nlm.nih.gov/pubmed/32722137
http://dx.doi.org/10.3390/cancers12082037
work_keys_str_mv AT allgowerchantal friendorfoes100proteinsincancer
AT kretzannalaura friendorfoes100proteinsincancer
AT vonkarstedtsilvia friendorfoes100proteinsincancer
AT wittaumathias friendorfoes100proteinsincancer
AT hennebrunsdoris friendorfoes100proteinsincancer
AT lemkejohannes friendorfoes100proteinsincancer